A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas
2期
已完成
NCT04917861
| 适应症 | Zika Virus |
|---|
| 分期 | 2期 |
|---|
| 申办方 | ModernaTX, Inc. |
|---|
| 状态 | 已完成 |
|---|
| 受试者人数 | 808 人 |
|---|
| 干预（药物） | mRNA-1893 |
|---|
| 开始日期 | 2021年6月7日 |
|---|
| 完成日期 | 2024年7月26日 |
|---|
| 结果公布日 | 2025年9月25日 |
|---|
摘要
This clinical study will evaluate the safety, tolerability, and reactogenicity of 2 dose levels of messenger RNA (mRNA)-1893 Zika vaccine in comparison to a placebo control in healthy participants who are flavivirus-seronegative and in participants who are flavivirus-seropositive.
Number of Participants With Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs)
Up to 7 days post-vaccination · Participants
| Placebo | 86 Participants |
|---|
| mRNA-1893 Low Dose (2-Dose Regimen) | 164 Participants |
|---|
| mRNA-1893 High Dose (2-Dose Regimen) | 183 Participants |
|---|
| mRNA-1893 High Dose (1-Dose Regimen) | 163 Participants |
|---|
Number of Participants With Unsolicited Adverse Events (AEs)
Up to 28 days post-vaccination · Participants
| Placebo | 39 Participants |
|---|
| mRNA-1893 Low Dose (2-Dose Regimen) | 47 Participants |
|---|
| mRNA-1893 High Dose (2-Dose Regimen) | 52 Participants |
|---|
| mRNA-1893 High Dose (1-Dose Regimen) | 45 Participants |
|---|
Number of Participants With Serious Adverse Events (SAEs), AEs of Special Interest (AESIs)
Day 1 through Day 196 for Main Study and Day 197 through Day 700 for Extension Period · Participants
| Main Study: Placebo | 5 Participants |
|---|
| Main Study: mRNA-1893 Low Dose (2-Dose Regimen) | 2 Participants |
|---|
| Main Study: mRNA-1893 High Dose (2-Dose Regimen) | 4 Participants |
|---|
| Main Study: mRNA-1893 High Dose (1-Dose Regimen) | 7 Participants |
|---|
| Extension Period: Placebo | 5 Participants |
|---|
| Extension Period: mRNA-1893 Low Dose (2-Dose Regimen) | 4 Participants |
|---|
在 BENITIONS 中查看
查看 ClinicalTrials.gov 原文
全部试验
本页整理自 ClinicalTrials.gov 的公开数据，不构成医疗建议，也不构成投资建议。请务必咨询专业医师。